{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:01:52Z","timestamp":1771351312070,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10072-026-08809-8","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:34:20Z","timestamp":1768973660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between interleukin-10 gene polymorphisms and multiple sclerosis susceptibility: evidence from a meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Yue-Long","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-272X","authenticated-orcid":false,"given":"Yu-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"8809_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","volume":"17","author":"S Rodr\u00edguez Mur\u00faa","year":"2022","unstructured":"Rodr\u00edguez Mur\u00faa S, Farez MF, Quintana FJ (2022) The Immune Response in Multiple Sclerosis. Annu Rev Pathol 17:121\u2013139. https:\/\/doi.org\/10.1146\/annurev-pathol-052920-040318","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"8809_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2217\/whe.10.69","volume":"6","author":"C Jobin","year":"2010","unstructured":"Jobin C, Larochelle C, Parpal H, Coyle PK, Duquette P (2010) Gender issues in multiple sclerosis: an update. Womens Health Lond 6(6):797\u2013820. https:\/\/doi.org\/10.2217\/whe.10.69","journal-title":"Womens Health Lond"},{"issue":"3","key":"8809_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000443","volume":"5","author":"E Rissanen","year":"2018","unstructured":"Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R, Rokka J, Gerhard A, Hinz R, Talbot PS, Rinne JO, Airas L (2018) Microglial activation, white matter tract damage, and disability in MS. Neurol Neuroimmunol Neuroinflamm 5(3):e443. https:\/\/doi.org\/10.1212\/nxi.0000000000000443","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"8809_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s1474-4422(18)30443-5","volume":"18","author":"GMS Collaborators","year":"2019","unstructured":"Collaborators GMS (2019) Global, regional, and National burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18(3):269\u2013285. https:\/\/doi.org\/10.1016\/s1474-4422(18)30443-5","journal-title":"Lancet Neurol"},{"issue":"4","key":"8809_CR5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/con.0000000000001136","volume":"28","author":"M Ward","year":"2022","unstructured":"Ward M, Goldman MD (2022) Epidemiology and pathophysiology of multiple sclerosis. Continuum (Minneap Minn) 28(4):988\u20131005. https:\/\/doi.org\/10.1212\/con.0000000000001136","journal-title":"Continuum (Minneap Minn)"},{"key":"8809_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578315","volume":"390","author":"S Sriwastava","year":"2024","unstructured":"Sriwastava S, Elkhooly M, Amatya S, Shrestha K, Kagzi Y, Bhatia D, Gupta R, Jaiswal S, Lisak RP (2024) Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis. J Neuroimmunol 390:578315. https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578315","journal-title":"J Neuroimmunol"},{"issue":"12","key":"8809_CR7","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1007\/s10787-025-02012-5","volume":"33","author":"DD Ghafoor","year":"2025","unstructured":"Ghafoor DD, Ahmad DO, Najmuldeen HH, Mohammed SJ, Jalal PJ, Mustafa FS, Alghofaili F, Zangana BA, Al-Bajalan SJ (2025) Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers. Inflammopharmacology 33(12):7269\u20137314. https:\/\/doi.org\/10.1007\/s10787-025-02012-5","journal-title":"Inflammopharmacology"},{"issue":"1","key":"8809_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01582-x","volume":"17","author":"NB Blackburn","year":"2025","unstructured":"Blackburn NB, McComish BJ, Motyer A, Slimmer JC, Leslie SJ, Broadley SA, Jokubaitis VG, Van Der Walt A, Kermode AG, Lechner-Scott J, Parnell GP, Fabis-Pedrini MJ, Scott RJ, Jackson S, Maltby VE, Charlesworth JC, Burdon KP, Taylor BV, Kilpatrick TJ, Rubio JP (2025) Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotype. Genome Med 17(1):149. https:\/\/doi.org\/10.1186\/s13073-025-01582-x","journal-title":"Genome Med"},{"issue":"11","key":"8809_CR9","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","volume":"147","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O\u2019Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147(11):3815\u20133822","journal-title":"J Immunol"},{"issue":"3","key":"8809_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva M, O\u2019Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10(3):170\u201381. https:\/\/doi.org\/10.1038\/nri2711","journal-title":"Nat Rev Immunol"},{"issue":"1\u20132","key":"8809_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0165-5728(01)00444-1","volume":"122","author":"K Strle","year":"2002","unstructured":"Strle K, Zhou JH, Broussard SR, Venters HD, Johnson RW, Freund GG, Dantzer R, Kelley KW (2002) IL-10 promotes survival of microglia without activating Akt. J Neuroimmunol 122(1\u20132):9\u201319. https:\/\/doi.org\/10.1016\/s0165-5728(01)00444-1","journal-title":"J Neuroimmunol"},{"key":"8809_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188750","volume":"14","author":"E Bugbee","year":"2023","unstructured":"Bugbee E, Wang AA, Gommerman JL (2023) Under the influence: environmental factors as modulators of neuroinflammation through the IL-10\/IL-10R axis. Front Immunol 14:1188750. https:\/\/doi.org\/10.3389\/fimmu.2023.1188750","journal-title":"Front Immunol"},{"key":"8809_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106540","volume":"100","author":"EM Khedr","year":"2025","unstructured":"Khedr EM, El-Deen HB, El-Mokhtar MA, Mahmoud DM (2025) Decoding disease burden in multiple sclerosis: the role of IL-10 as biomarker of neuroinflammation and neurodegeneration. Mult Scler Relat Disord 100:106540. https:\/\/doi.org\/10.1016\/j.msard.2025.106540","journal-title":"Mult Scler Relat Disord"},{"key":"8809_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jneuroim.2017.02.015","volume":"306","author":"V Ramakrishnan","year":"2017","unstructured":"Ramakrishnan V, Akram Husain RS, Ahmed SS (2017) Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: a meta-analysis. J Neuroimmunol 306:11\u201318. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.02.015","journal-title":"J Neuroimmunol"},{"key":"8809_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"2","key":"8809_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989x.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11(2):193\u2013206. https:\/\/doi.org\/10.1037\/1082-989x.11.2.193","journal-title":"Psychol Methods"},{"issue":"4","key":"8809_CR17","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719\u2013748","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"8809_CR18","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/(sici)1097-0258(19960630)15:12<1237::Aid-sim301>3.0.Co;2-n","volume":"15","author":"R DerSimonian","year":"1996","unstructured":"DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15(12):1237\u201348.\u00a0https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960630)15:12%3C;1237::AID-SIM301%3E;3.0.CO;2-N","journal-title":"Stat Med"},{"issue":"4","key":"8809_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088\u20131101","journal-title":"Biometrics"},{"issue":"2","key":"8809_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0165-5728(99)00146-0","volume":"101","author":"C Pickard","year":"1999","unstructured":"Pickard C, Mann C, Sinnott P, Boggild M, Hawkins C, Strange RC, Hutchinson IV, Ollier WE, Donn RP (1999) Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis. J Neuroimmunol 101(2):207\u2013210. https:\/\/doi.org\/10.1016\/s0165-5728(99)00146-0","journal-title":"J Neuroimmunol"},{"issue":"1","key":"8809_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/s0165-5728(99)00256-8","volume":"104","author":"M M\u00e4urer","year":"2000","unstructured":"M\u00e4urer M, Kruse N, Giess R, Toyka KV, Rieckmann P (2000) Genetic variation at position \u2013\u20091082 of the Interleukin 10 (IL10) promotor and the outcome of multiple sclerosis. J Neuroimmunol 104(1):98\u2013100. https:\/\/doi.org\/10.1016\/s0165-5728(99)00256-8","journal-title":"J Neuroimmunol"},{"issue":"4","key":"8809_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0198-8859(02)00369-5","volume":"63","author":"BA de Jong","year":"2002","unstructured":"de Jong BA, Westendorp RG, Eskdale J, Uitdehaag BM, Huizinga TW (2002) Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Hum Immunol 63(4):281. https:\/\/doi.org\/10.1016\/s0198-8859(02)00369-5","journal-title":"Hum Immunol"},{"issue":"1\u20132","key":"8809_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0022-510x(02)00246-0","volume":"202","author":"KM Myhr","year":"2002","unstructured":"Myhr KM, V\u00e5gnes KS, Mar\u00f8y TH, Aarseth JH, Nyland HI, Vedeler CA (2002) Interleukin-10 promoter polymorphisms in patients with multiple sclerosis. J Neurol Sci 202(1\u20132):93\u201397. https:\/\/doi.org\/10.1016\/s0022-510x(02)00246-0","journal-title":"J Neurol Sci"},{"issue":"6","key":"8809_CR24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1034\/j.1600-0404.2003.00165.x","volume":"108","author":"M Luomala","year":"2003","unstructured":"Luomala M, Lehtim\u00e4ki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I (2003) Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta Neurol Scand 108(6):396\u2013400. https:\/\/doi.org\/10.1034\/j.1600-0404.2003.00165.x","journal-title":"Acta Neurol Scand"},{"issue":"1\u20132","key":"8809_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jneuroim.2005.06.020","volume":"168","author":"S Mihailova","year":"2005","unstructured":"Mihailova S, Ivanova M, Mihaylova A, Quin L, Mikova O, Naumova E (2005) Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J Neuroimmunol 168(1\u20132):138\u2013143. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.06.020","journal-title":"J Neuroimmunol"},{"key":"8809_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1196\/annals.1354.034","volume":"1067","author":"GI Forte","year":"2006","unstructured":"Forte GI, Ragonese P, Salemi G, Scola L, Candore G, D\u2019Amelio M, Crivello A, Di Benedetto N, Nuzzo D, Giacalone A, Lio D, Caruso C (2006) Search for genetic factors associated with susceptibility to multiple sclerosis. Ann N Y Acad Sci 1067:264\u20139. https:\/\/doi.org\/10.1196\/annals.1354.034","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"8809_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/MAJ.0b013e3181cef1a1","volume":"339","author":"M Izad","year":"2010","unstructured":"Izad M, Vodjgani M, Niknam MH, Amirzargar A, Shahbeigi S, Heidari AB, Keramatipour M (2010) Cytokines genes polymorphisms and risk of multiple sclerosis. Am J Med Sci 339(4):327\u2013331. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181cef1a1","journal-title":"Am J Med Sci"},{"issue":"2","key":"8809_CR28","first-page":"107","volume":"19","author":"N Azarpira","year":"2010","unstructured":"Azarpira N, Borhani Haghighi A, Pourjafar M, Shariat A (2010) Interleukin 10 gene polymorphism in Iranian patients with multiple sclerosis. Acta Neurol Taiwan 19(2):107\u2013111","journal-title":"Acta Neurol Taiwan"},{"issue":"1\u20132","key":"8809_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.04.014","volume":"236","author":"D Mirowska-Guzel","year":"2011","unstructured":"Mirowska-Guzel D, Gromadzka G, Mach A, Czlonkowski A, Czlonkowska A (2011) Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-\u03b1 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunol 236(1\u20132):87\u201392. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.04.014","journal-title":"J Neuroimmunol"},{"issue":"6","key":"8809_CR30","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4103\/ijmr.IJMR_1225_15","volume":"145","author":"M Shahbazi","year":"2017","unstructured":"Shahbazi M, Abadi JSA, Roshandel D, Koochaki M, Amiri H, Kohansal R, Baghbanian SM, Zamani M (2017) Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis. Indian J Med Res 145(6):746\u2013752. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1225_15","journal-title":"Indian J Med Res"},{"issue":"11","key":"8809_CR31","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s10072-019-04000-4","volume":"40","author":"MA Al-Naseri","year":"2019","unstructured":"Al-Naseri MA, Salman ED, Ad\u2019hiah AH (2019) Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients. Neurol Sci 40(11):2383\u20132389. https:\/\/doi.org\/10.1007\/s10072-019-04000-4","journal-title":"Neurol Sci"},{"issue":"3","key":"8809_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.22034\/iji.2021.83883.1634","volume":"18","author":"M Asgharzadeh","year":"2021","unstructured":"Asgharzadeh M, Sanajoo D, Mahdavi Poor B, Samadi Kafil H, Gholizadeh P, Rashedi J (2021) Interleukin-10 promoter and the CCR5 polymorphisms in Iranian Azari population with multiple sclerosis. Iran J Immunol 18(3):241\u2013248. https:\/\/doi.org\/10.22034\/iji.2021.83883.1634","journal-title":"Iran J Immunol"},{"key":"8809_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12060800","author":"U Masilionyte","year":"2022","unstructured":"Masilionyte U, Gedvilaite G, Kaikaryte K, Vilkeviciute A, Kriauciuniene L, Glebauskiene B, Balnyte R, Liutkeviciene R (2022) IL-10 gene polymorphisms and IL-10 serum levels in patients with multiple sclerosis in Lithuania. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12060800","journal-title":"Brain Sci"},{"issue":"20","key":"8809_CR34","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R (2022) What is multiple sclerosis? JAMA 328(20):2078. https:\/\/doi.org\/10.1001\/jama.2022.14236","journal-title":"JAMA"},{"issue":"3","key":"8809_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/wnl.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr., Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O\u2019Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, St\u00fcve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u201386. https:\/\/doi.org\/10.1212\/wnl.0000000000000560","journal-title":"Neurology"},{"issue":"1","key":"8809_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22074\/cellj.2016.4867","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E (2017) Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J 19(1):1\u201310. https:\/\/doi.org\/10.22074\/cellj.2016.4867","journal-title":"Cell J"},{"issue":"4","key":"8809_CR37","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97(4):742\u2013768. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.021","journal-title":"Neuron"},{"issue":"2","key":"8809_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-3083.1995.tb03550.x","volume":"41","author":"V Navikas","year":"1995","unstructured":"Navikas V, Link J, Palasik W, S\u00f6derstr\u00f6m M, Fredrikson S, Olsson T, Link H (1995) Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand J Immunol 41(2):171\u2013178. https:\/\/doi.org\/10.1111\/j.1365-3083.1995.tb03550.x","journal-title":"Scand J Immunol"},{"issue":"6","key":"8809_CR39","first-page":"643","volume":"93","author":"ML Batista Jr","year":"2009","unstructured":"Batista ML Jr., Lopes RD, Seelaender MC, Lopes AC (2009) Anti-inflammatory effect of physical training in heart failure: role of TNF-alpha and IL-10. Arq Bras Cardiol 93(6):643\u2013651","journal-title":"Arq Bras Cardiol"},{"key":"8809_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577881","volume":"368","author":"M Hemmerich","year":"2022","unstructured":"Hemmerich M, Malorny N, Lewen A, Hollnagel JO, Chausse B, Kann O (2022) Priming of microglia by type II interferon is lasting and resistant to modulation by interleukin-10 in situ. J Neuroimmunol 368:577881. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577881","journal-title":"J Neuroimmunol"},{"issue":"1","key":"8809_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","volume":"24","author":"DM Turner","year":"1997","unstructured":"Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24(1):1\u20138. https:\/\/doi.org\/10.1111\/j.1365-2370.1997.tb00001.x","journal-title":"Eur J Immunogenet"},{"issue":"5","key":"8809_CR42","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.Tp.0000055216.19866.9a","volume":"75","author":"A Su\u00e1rez","year":"2003","unstructured":"Su\u00e1rez A, Castro P, Alonso R, Mozo L, Guti\u00e9rrez C (2003) Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75(5):711\u2013717. https:\/\/doi.org\/10.1097\/01.Tp.0000055216.19866.9a","journal-title":"Transplantation"},{"issue":"1","key":"8809_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10753-012-9517-7","volume":"36","author":"MN Karimabad","year":"2013","unstructured":"Karimabad MN, Arababadi MK, Hakimizadeh E, Daredori HY, Nazari M, Hassanshahi G, Kennedy D (2013) Is the IL-10 promoter polymorphism at position \u2013 592 associated with immune system-related diseases? Inflammation 36(1):35\u201341. https:\/\/doi.org\/10.1007\/s10753-012-9517-7","journal-title":"Inflammation"},{"issue":"2","key":"8809_CR44","first-page":"154","volume":"16","author":"D Guzowski","year":"2005","unstructured":"Guzowski D, Chandrasekaran A, Gawel C, Palma J, Koenig J, Wang XP, Dosik M, Kaplan M, Chu CC, Chavan S, Furie R, Albesiano E, Chiorazzi N, Goodwin L (2005) Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech 16(2):154\u2013166","journal-title":"J Biomol Tech"},{"issue":"7","key":"8809_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.humimm.2015.06.009","volume":"76","author":"M V\u00e1zquez-Villamar","year":"2015","unstructured":"V\u00e1zquez-Villamar M, Palafox-S\u00e1nchez CA, Mu\u00f1oz-Valle JF, Valle Y, Orozco-Barocio G, Hern\u00e1ndez-Bello J, Oregon-Romero E (2015) Analysis of IL10 haplotypes in primary Sj\u00f6gren\u2019s syndrome patients from Western mexico: relationship with mRNA expression, IL-10 soluble levels, and autoantibodies. Hum Immunol 76(7):473\u2013479. https:\/\/doi.org\/10.1016\/j.humimm.2015.06.009","journal-title":"Hum Immunol"},{"key":"8809_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cyto.2017.02.022","volume":"95","author":"J Hern\u00e1ndez-Bello","year":"2017","unstructured":"Hern\u00e1ndez-Bello J, Oreg\u00f3n-Romero E, V\u00e1zquez-Villamar M, Garc\u00eda-Arellano S, Valle Y, Padilla-Guti\u00e9rrez JR, Rom\u00e1n-Fern\u00e1ndez IV, Palafox-S\u00e1nchez CA, Mart\u00ednez-Bonilla GE, Mu\u00f1oz-Valle JF (2017) Aberrant expression of interleukin-10 in rheumatoid arthritis: relationship with IL10 haplotypes and autoantibodies. Cytokine 95:88\u201396. https:\/\/doi.org\/10.1016\/j.cyto.2017.02.022","journal-title":"Cytokine"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08809-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:03:04Z","timestamp":1771347784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08809-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["8809"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08809-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All pooled data were collected from published studies, and no ethical issues were involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There are no human subjects in this article and informed consent is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"184"}}